CLASS II ONGOING Drug recall · Reported 22 Oct 2025 · FDA Enforcement Report
Aloe Up Sport Performance Sunscreen Lotion SPF 30 per tube recalled
SV Labs Prescott is recalling Aloe Up Sport Performance Sunscreen Lotion SPF 30 per tube, distributed nationwide in the US. The recall was initiated on 25 Sep 2025 and the FDA has classified it as Class II.
Check your package
Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.
Recall details
- Recall number
- D-0022-2026
- FDA event ID
- 97652
- Recalling firm
- SV Labs Prescott, Prescott, WI
- Classification
- Class II
- Status
- Ongoing
- Recall initiated
- 25 Sep 2025
- FDA classified
- 15 Oct 2025
- Reported
- 22 Oct 2025
- Type
- Voluntary: Firm initiated
- Customers notified by
- Letter
- Reason category
- Manufacturing (CGMP) Deviations
- Drug class
- Creams, Ointments & Gels
Timeline
| 25 Sep 2025 | Recall initiated by company | |
| 15 Oct 2025 | Classified by FDA | +20 days |
| 22 Oct 2025 | Published in enforcement report | +7 days |
Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.
Reason for recall
cGMP deviations: the firm released and distributed product which failed total aerobic microbial count testing.
Product as listed by the FDA
Aloe Up Sport Performance Sunscreen Lotion SPF 30, 1 FL OZ (30 mL) per tube, Mfd. for: ALOE UP, 9700 W. 76th St., Ste 112, Eden Prairie, Minnesota 55344
Where it was distributed
USA Nationwide
Questions about this recall
Why was it recalled?
cGMP deviations: the firm released and distributed product which failed total aerobic microbial count testing.
Which lots are affected?
Lot#: 25196, Exp 2/16/2026
Where was it sold?
USA Nationwide
What should I do if I have it?
Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.
What does Class II mean?
Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.
Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.